IGM Biosciences to Present at Two Upcoming Investor Conferences

MOUNTAIN VIEW, Calif., March 04, 2020  — IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced that members of the management team will present at two upcoming investor conferences:

  • Barclays Global Healthcare Conference on Wednesday, March 11 at 3:20 p.m. ET in Miami.
  • Oppenheimer 30th Annual Healthcare Conference on Wednesday, March 18 at 8:35 a.m. ET in New York.

A live webcast of the events will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investor.igmbio.com/news-and-events/events-and-presentations. A replay of the webcasts will be archived on the Company’s website for 90 days following the presentation.

About IGM Biosciences, Inc.
Headquartered in Mountain View, California, IGM Biosciences is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies. Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. Through its efforts, IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies.

Contact:

Argot Partners
David Pitts
212-600-1902
igmbio@argotpartners.com

IGM Biosciences to Present at Two Upcoming Investor Conferences

MOUNTAIN VIEW, Calif., Feb. 06, 2020 – IGM Biosciences, Inc. (Nasdaq: IGMS), a global leader in the research and development of engineered therapeutic IgM antibodies, today announced that Fred Schwarzer, Chief Executive Officer, will present at two upcoming investor conferences:

  • Guggenheim Healthcare Talks Idea Forum Oncology Day on Thursday, February 13 at 1:30 p.m. ET in New York.
  • Cowen and Company 40th Annual Health Care Conference on Monday, March 2 at 2:10 p.m. ET in Boston.

A live webcast of the events will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investor.igmbio.com/news-and-events/events-and-presentations. A replay of the webcasts will be archived on the Company’s website for 90 days following the presentation.

About IGM Biosciences, Inc.
Headquartered in Mountain View, California, IGM Biosciences is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies for the treatment of cancer patients. Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. Through its efforts, IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies.

Contact:

Argot Partners
David Pitts
212-600-1902
igmbio@argotpartners.com

IT – Sr. Technical Support Engineer & Administrator

We are seeking an experienced technical support engineer and administrator who can succeed in multiple roles in our expanding early stage biotechnology company of 60 plus. In this dynamic role, you will be the IT point person providing maintenance and support for all facets of the existing computing environment including hardware, software, network, and servers. You will also assist with the evaluation and deployment of business applications and other projects.

The ideal candidate will be a versatile individual who has both a “roll up the sleeves” mentality and excellent customer service skills and can forge ahead independently with minimal direct supervision. A big plus would be someone who also possesses strategic and technical experience in a corporate setting. For the right candidate, this can be a growth position with an opportunity to lead the creation and management of the company’s processes and technology roadmaps. In this role, you will report to the CEO.

Responsibilities:

  • Timely response to and effective technical support for all areas within the corporate computing infrastructure including laptops, lab desktops, applications, mobile devices, and network connectivity.
  • Manage inventory, distribution and setup of computers, software and other IT assets.
  • Manage business systems and applications including telephone/communications systems, internet service, security systems, audio/visual and display equipment, room reservation system, printers, domain accounts, Office 365, and VPN.
  • Assess, provision, install/configure, operate, and deploy third-party applications for integration and implementation into the existing infrastructure, i.e., ERP system.
  • Collaborate with our consulting systems engineer in maintaining Windows server, systems hardware and software, network and related infrastructure.
    Identify network and security vulnerabilities and develop solutions to mitigate the risks and be able to apprise executive management and the board of directors of findings.
  • Maintain and keep current the knowledge base, process and inventory documentation.

Qualifications:

  • Bachelor’s degree or equivalent experience.
  • 5+ years of relevant IT experience, preferably some in biotech.
  • Positive, can-do attitude with strong interpersonal and communication skills to work with all levels in the company from entry level personnel to board of directors.
  • Approachable and responsive user support attitude.
  • Strong technical skills and adept at problem solving, diagnosis and troubleshooting.
  • Self-starter with capability to complete tasks & projects with minimal direct supervision.
  • Ability to work under pressure and multi-task in a fast-paced environment.
  • Experience in selection, implementation and ongoing administration of an ERP system, preferably in a manufacturing-intensive biotech company, is helpful.
  • Working knowledge of collaboration and communications platforms, i.e., Box, Office 365.
  • Advanced knowledge of a range of computer systems, software, applications, hardware, and PC and Mac operating systems.
  • Knowledge of Windows network computing and networking fundamentals.
  • Knowledge of applicable regulatory requirements, data privacy practices and laws as they relate to the management of IT Infrastructure in GMP environments is helpful.
  • Public company experience is helpful.
  • Must be able to commute daily to Mountain View and work on-site. Must be available for emergency assistance off-site on nights and weekends.

IGM is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity or expression, national origin or ancestry, age, disability, marital status and veteran status. All qualified applicants will receive consideration for employment.

 
Apply to this position

IGM Biosciences Appoints Eric Humke, M.D., Ph.D., as Vice President, Clinical Development, Apoptosis

Expert in the research and development of apoptotic pathways and antibody drug conjugates.

MOUNTAIN VIEW, Calif., January 7, 2020IGM Biosciences, Inc. (Nasdaq: IGMS), a global leader in the research and development of engineered therapeutic IgM antibodies, today announced the appointment of Eric Humke, M.D., Ph.D., to the newly created position of Vice President, Clinical Development, Apoptosis. Dr. Humke will join Daniel S. Chen, Chief Medical Officer, and Wayne Godfrey, Vice President, Clinical Development, to lead the global clinical development of IGM’s emerging pipeline of proprietary IgM antibodies.

“Eric’s experience in developing numerous first-in-human therapeutics in multiple cancer indications, including several different antibody drug conjugates, will provide strong support for the expansion of the clinical development of our industry-leading IgM technology platform,” said Fred Schwarzer, Chief Executive Officer of IGM Biosciences.

Dr. Humke commented, “Apoptotic, also known as programmed cell death, pathways are highly conserved throughout evolution, and evasion of cell death is absolutely fundamental to the formation of cancer. Targeting of these pathways may have immense therapeutic potential for treating cancer and needs to be realized.  I believe IGM’s innovative and proprietary approach to engineering and producing IgM-based agonists is an excellent match for this biology, and I am extremely excited to have the opportunity to build and lead the clinical research and development efforts in apoptosis at IGM Biosciences.”

Dr. Humke joins IGM with more than 15 years of experience in apoptosis research and early clinical development of first-in-human therapeutics in solid tumors, most recently serving as Senior Medical Director at Genentech. While at Genentech, he led multiple clinical investigation programs in Research & Early Clinical Development, including the study of six different antibody drug conjugates in lung, ovarian, and endometrial cancer, as well as multiple myeloma. Prior to joining Genentech, he was an Instructor of Medicine in the Division of Oncology at the Stanford University School of Medicine where he conducted research and clinical studies.

“Eric studied apoptosis biology with Vishva Dixit at the University of Michigan and at Genentech, during a time when they discovered and characterized many of these critical pathways, including death receptor 5 (DR5). Those early studies performed by Dr. Humke and others in the Dixit lab represents the foundation of our understanding of these critical cellular death and survival factors for cancer. However, therapeutic technologies needed to optimally target trimerizing Tumor Necrosis Super Family Receptors (TNSFRs) such as DR5 have been lacking,” said Daniel S. Chen, Chief Medical Officer of IGM Biosciences. Dr. Chen continued, “With our multimerizing IgM anti-DR5 agonists, we look forward to Eric leveraging his depth of apoptotic scientific expertise and early clinical development experience in solid tumor indications to lead these programs and further extend IGM’s clinical development capabilities.”

Dr. Humke has co-authored multiple clinical and scientific publications and book chapters. He earned a B.S. at Brown University and an M.D., Ph.D. from the University of Michigan. He completed his internal medicine residency at Washington University in St. Louis (Barnes-Jewish Hospital) and a medical oncology fellowship at Stanford University.

About IGM Biosciences, Inc.

Headquartered in Mountain View, California, IGM Biosciences is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies for the treatment of cancer patients. Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. Through its efforts, IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Forward-looking statements generally relate to future events or IGM Biosciences’ future plans, strategy and performance. Such statements are subject to numerous important factors, risks and uncertainties that may cause actual events or results to differ materially, including those more fully described in IGM Biosciences’ filings with the Securities and Exchange Commission (“SEC”), including IGM Biosciences’ Quarterly Report on Form 10-Q filed with the  SEC on November 7, 2019 and in IGM Biosciences’ future reports to be filed with the SEC.  Any forward-looking statements contained in this press release speak only as of the date hereof, and IGM Biosciences specifically disclaims any obligation to update any forward-looking statement, except as required by law.

Contact:

Argot Partners
David Pitts
212-600-1902
igmbio@argotpartners.com

Executive Assistant

In this integral new position at IGM as an Executive Assistant, you will provide senior level administrative support to our CSO, CMO, CEO, and CFO. In this highly visible role, you will handle details of a confidential nature, and must always be able to maintain professional and ethical standards.

Responsibilities:

  • Proactively manage calendars and schedules.
  • Coordinate meeting logistics both internally and externally.
  • Be responsive to requests for assistance from and communicate professionally with members of the board.
  • Coordinate logistics with respect to board meetings.
  • Email management.
  • Coordinate all aspects of travel arrangements.
  • Assist with documentation preparation, such as presentations and reports.
  • Conduct routine administrative duties as necessary.

Qualifications:

  • 5+ years supporting senior management as an Executive Assistant.
  • Extremely well organized.
  • Able to multi-task.
  • Proficient in the Microsoft Office Suite.
  • Familiarity with Concur is helpful.
  • Excellent oral and written skills.
  • Strong decision-making skills.
  • Must be able to navigate ambiguity with limited guidance.
  • Must be able to work with employees at all levels at IGM.
  • Able to manage competing priorities.
  • Must enjoy working in a fast paced, entrepreneurial environment.
  • Prior experience in life sciences/biotech is helpful.

IGM is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity or expression, national origin or ancestry, age, disability, marital status and veteran status. All qualified applicants will receive consideration for employment.

 
Apply to this position

Research Associate / Senior Research Associate, Biomarkers

Our Preclinical Sciences group is looking for a Research Associate with a background in Immunology, Cell Biology or a related scientific discipline to join our growing and friendly team during this exciting time in our expansion. You will play an integral role in the preclinical development of novel antibody-based therapeutics in a variety of disease areas and at various stages of development.

Responsibilities:

  • Human and mouse cell culture and primary cell maintenance and isolation.
  • Design, develop and execute in vitro cell-based immunoassays.
  • Perform analysis with ELISAs other methods of cytokine/analyte analysis.
  • Utilize multicolor flow cytometry in analysis.
  • Execute basic biochemical assays (eg. Western blot).
  • Communicate own work effectively orally and in writing; present data in group meetings.
  • Thoroughly and accurately document experimental activities in laboratory notebooks.

Qualifications:

  • BS or higher degree in Immunology, Cell Biology or related scientific discipline.
  • 3-5 + years of relevant industry or academic experience.
  • Must have hands-on experience in multi-color flow cytometry, and in vitro cell-based immunoassays.
  • Experience evaluating T cell engagers and other antibody therapeutics is a plus.
  • Proficient with basic computer programs routinely used in a lab such as MS Word, Excel, and PowerPoint, GraphPad Prism, and FlowJo.
  • Highly organized with reliable time-keeping skills and able to maintain a detailed and well-organized notebook.
  • Must be a team player, respectful of others, and have strong interpersonal and communication skills.
  • Able to thrive in a fast-paced, start-up environment.
  • Able to commute to Mountain View.

IGM is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity or expression, national origin or ancestry, age, disability, marital status and veteran status. All qualified applicants will receive consideration for employment.

 
Apply to this position

Upstream Manufacturing Manager

We are hiring a Manager for the Upstream Manufacturing group to join our rapidly growing team. In this important position, you will build and manage a team to execute CHO based cell culture processes following GMP guidance, generating clarified Harvested Cell Culture Fluid (HCCF) to be used for further manufacturing by the Downstream manufacturing team. This role will also include a close working relationship with the Process Development team to perform technology transfer of multiple molecules to support GMP level manufacturing. These efforts are all focused to help advance novel cancer therapies into human clinical studies.

Responsibilities:

  • Experience with operating benchtop bioreactors, pilot scale bioreactors and mini bioreactors such as AMBR250 preferred but not required.
  • Scale up cell culture processes to a 1000 L disposable stirred tank bioreactor.
  • Collaborate closely with Upstream and Downstream development, Downstream manufacturing and Quality groups to meet project timelines.
  • Lead the technology transfer of cell culture processes from the development group into GMP manufacturing.
  • Enhance cell culture process understanding and participate in platform optimization efforts.
  • Expertise with media/feed optimization and perfusion cultures is a plus.
  • Write clear and concise Standard Operating Procedures (SOP’s), Production Documents and forms/addenda to facilitate GMP manufacturing.
  • Perform timely production reviews on operator completed GMP documentation and batch records.
  • Contribute to GMP campaign summary reports, relevant CMC sections in regulatory filings and technical development reports.
  • Hire train and develop an efficient well-developed upstream operations team.
  • Manage and evaluate the team holding direct reports accountable for performance.
  • Partner with Quality and Safety to ensure best efforts compliance.
  • Drive process improvement and metric progress in key areas of responsibility: safety/culture, quality/delivery, cost-effectiveness, efficiency.
  • Support the Request For Proposal (RFP) and diligence process for all external manufacturing contracts.

Qualifications:

  • B.S. degree in Engineering, Life Science or related field, and 5+ years in manufacturing biologics under GMP to support FDA/EMA approved clinical trials.
  • Minimum of 2 years of management and leadership experience.
  • Knowledge of GMP manufacturing requirements related to clinical production and commercial manufacturing of injectable products.
  • Lean Manufacturing implementation experience preferred.
  • Experience operating single use upstream manufacturing processes considered a plus.
  • Strong leader and mentor.
  • Excellent verbal and written communication.
  • Proficiency using Microsoft Office, relational databases, cloud-based document control systems (i.e. TrackWise, Veeva, Master Control etc.) and graphing programs.
  • Aseptic technique.
  • Able to multitask.
  • Extremely well organized with great attention to detail.
  • Able to thrive in a fast-paced, start-up environment.
  • “Roll up the sleeves” mentality.
  • Must be able to commute to Mountain View, CA.

Working environment:

  • This job involves working under BSL-1 conditions.
  • Capable of lifting upwards of 50 pounds infrequently.

IGM is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity or expression, national origin or ancestry, age, disability, marital status and veteran status. All qualified applicants will receive consideration for employment.

 
Apply to this position

Downstream Scientist/Sr. Scientist

We are seeking a Scientist or Senior Scientist with significant experience in process development particularly in the context of antibody and antibody-like biologics. The ideal candidate will have a solid background in protein purification and bioanalytical techniques used to characterize biologics. This is a key position in the Process Sciences and Manufacturing group and will have the opportunity to collaborate across groups to contribute to multiple fast-moving drug discovery projects.

Responsibilities

  • Operate and maintain instrumentation for the analysis and purification of antibodies.
  • Develop and perform protein and antibody purification by chromatography and filtration technology.
  • Tech transfer purification processes to internal and/or external manufacturing groups.
  • Characterize protein and antibody targets using typical analytical methods (SDS-PAGE, SEC, endotoxin, etc.).
  • Keep accurate and current records of research and/or project related activities in laboratory notebooks.
  • Prepare technical reports, summaries of testing, and detailed protocols.
  • Share data with management and team members.
  • Research literature to identify novel methodologies and solve scientific problems and apply to the overall program.
  • Publish research in peer-reviewed journals and present work at scientific conferences when possible.
  • May supervise one or more direct reports and proactively engage in their development.

Qualifications

  • Ph.D. degree biology, biochemistry, chemical engineering or related fields with at least two (2) years of experience or Bachelor/Master’s with more than five (5) years of post-degree experience in the biopharma industry, preferably in a fast-paced startup environment.
  • Extensive experience in protein purification using a variety of chromatographic techniques with hands-on experience using and maintaining AKTA FPLC (AVANT, Pure, Ready) systems with Unicorn software.
  • Prior experience interacting with CROs/CMOs for manufacturing and characterizing biologics.
  • Experience with viral and tangential flow filtration.
  • Demonstrated experience with analytics and characterization of proteins and antibodies (SDS-PAGE, Western Blot, residual Host Cell Proteins, residual DNA, HPLC).
  • Ability to evaluate purification processes for scalability, cost and quality and then transfer to CMO.
  • Experience with designing and performing DOE is a plus.
  • Good understanding of biophysical techniques such as DSF, DSC, DLS, IEF is preferred.
  • Ability to work independently or with limited direct supervision.
  • Excellent organization, interpersonal, and communication skills and ability to clearly and effectively present data at group and company meetings
  • Consummate team player and respectful of others is a must.
  • Must be able to commute to Mountain View.

IGM is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity or expression, national origin or ancestry, age, disability, marital status and veteran status. All qualified applicants will receive consideration for employment.

 
 
Apply to this position

Downstream Manufacturing Manager

We are hiring a Manager for the Downstream Manufacturing group to join our rapidly growing team. In this important position, you will build and manage a team to execute monoclonal antibody based downstream processes following GMP guidance, generating bulk drug substance to be used for further manufacturing by contracted fill and finish organizations. This role will also include a close working relationship with the Process Development team to perform technology transfer of multiple molecules to support GMP level manufacturing. These efforts are all focused to help advance novel cancer therapies into human clinical studies.

Responsibilities:

  • Experience with operating ÄKTA purification systems and UNICORN 7 (or equivalent) required.
  • Expertise and understanding of large protein molecule/monoclonal antibody separation and impurity clearance from harvested cell culture fluid, based on size, physico-chemical properties and binding affinity.
  • Experience with packing and unpacking multiple types of resins/media to perform capture, elution and polishing required.
  • Experience with operating TFF/UFDF skids and viral inactivation and filtration required.
  • Collaborate closely with Upstream and Downstream development, Upstream manufacturing and Quality groups to meet project timelines.
  • Lead the technology transfer of purification processes from the development group into GMP manufacturing.
  • Enhance antibody purification process understanding and participate in platform optimization efforts.
  • Write clear and concise Standard Operating Procedures (SOP’s), Production Documents and forms/addenda to facilitate GMP manufacturing.
  • Perform timely production reviews on operator completed GMP documentation and batch records.
  • Contribute to GMP campaign summary reports, relevant CMC sections in regulatory filings and technical development reports.
  • Hire, train and develop an efficient well-developed downstream operations team.
  • Manage and evaluate the team holding direct reports accountable for performance.
  • Partner with Quality and Safety to ensure best efforts compliance.
  • Drive process improvement and metric progress in key areas of responsibility: safety/culture, quality/delivery, cost-effectiveness, efficiency.
  • Support the Request For Proposal (RFP) and diligence process for all external manufacturing contracts.

Qualifications:

  • B.S. degree in Engineering, Life Science or related field, and 5+ years in manufacturing biologics under GMP to support FDA/EMA approved clinical trials.
  • Minimum of 2 years of management and leadership experience.
  • Knowledge of GMP manufacturing requirements related to clinical production and commercial manufacturing of injectable products.
  • Lean Manufacturing implementation experience preferred.
  • Experience operating single use downstream manufacturing processes considered a plus
  • Strong leader and mentor.
  • Excellent verbal and written communication.
  • Proficiency using Microsoft Office, relational databases, cloud-based document control systems (i.e. TrackWise, Veeva, Master Control etc.) and graphing programs.
  • Aseptic technique.
  • Able to multitask.
  • Extremely well organized with great attention to detail.
  • Able to thrive in a fast-paced, start-up environment.
  • “Roll up the sleeves” mentality.
  • Must be able to commute to Mountain View, CA.

Working environment:

  • This job involves working under BSL-1 conditions.
  • Capable of lifting upwards of 50 pounds infrequently.

IGM is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity or expression, national origin or ancestry, age, disability, marital status and veteran status. All qualified applicants will receive consideration for employment.

Apply to this position